Immunic Operating Expenses | IMUX

Annual Operating Expenses Immunic

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
103 M	98.1 M	99.2 M	119 M	91.7 M	49 M	37 M	38.4 M	52.7 M	41.3 M	52.1 M	50.3 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
119 M	37 M	69.4 M

Quarterly Operating Expenses Immunic

2026-Q2	2026-Q1	2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
27.1 M	33.2 M	-	26 M	27.1 M	26.8 M	-	25.7 M	22.8 M	23.9 M	-	23.6 M	25 M	27.3 M	-	20.1 M	20.6 M	21.4 M	21.7 M	18.4 M	19.2 M	32.4 M	14.2 M	13.5 M	12.2 M	9.01 M	8.19 M	9.18 M	15 M	4.66 M	5.23 M	1.8 M	2.67 M	2.29 M	14.8 M	12.6 M	12.5 M	12.7 M	11.8 M	10.2 M	9.55 M	9.66 M	9.89 M	12.3 M	15.1 M	14.8 M	14 M	12.8 M	11.6 M	11.9 M	10.2 M	9.16 M	7.06 M	4.93 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
33.2 M	1.8 M	15.4 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Celsion Corporation CLSN	14.7 M	-	-6.63 %	$ 13.9 M	USA
FSD Pharma HUGE	15.3 M	-	5743.5 %	$ 69.7 M	Canada
Codexis CDXS	31.5 M	$ 1.42	0.33 %	$ 124 M	USA
Synthetic Biologics SYN	24.1 M	-	1.32 %	$ 16.2 M	USA
Dynavax Technologies Corporation DVAX	137 M	-	-	$ 2.02 B	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Qilian International Holding Group Limited QLI	2.16 M	-	-6.08 %	$ 184 M	China
Happiness Biotech Group Limited HAPP	17.1 M	-	1.35 %	$ 17.8 M	China
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Cue Biopharma CUE	54 M	$ 27.67	2.63 %	$ 2.62 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	78.4 M	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	170 M	-	-	$ 4.9 B	Britain
Завод ДИОД DIOD	249 M	-	-	-	Russia
Galera Therapeutics GRTX	70.6 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Hepion Pharmaceuticals HEPA	4.16 M	-	-18.79 %	$ 39.3 K	USA
ARCA biopharma ABIO	122 M	-	1052.0 %	$ 415 M	USA
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Editas Medicine EDIT	201 M	$ 3.08	0.33 %	$ 273 M	USA
Ardelyx ARDX	95.9 M	$ 3.71	1.06 %	$ 894 M	USA
Affimed N.V. AFMD	54 M	-	-34.95 %	$ 21.5 M	Germany
EyePoint Pharmaceuticals EYPT	275 M	$ 4.57	0.21 %	$ 335 K	USA
Arcutis Biotherapeutics ARQT	305 M	$ 23.66	0.04 %	$ 3.01 B	USA
Assembly Biosciences ASMB	84.4 M	$ 36.13	4.38 %	$ 405 M	USA
Fate Therapeutics FATE	154 M	$ 2.42	0.61 %	$ 287 M	USA
AnPac Bio-Medical Science Co., Ltd. ANPC	106 M	-	-1.58 %	$ 28.1 M	China
Celyad Oncology SA CYAD	26.2 M	-	-	$ 12.5 M	Belgium
Adial Pharmaceuticals ADIL	7.8 M	$ 6.66	5.38 %	$ 4.45 M	USA
Fortress Biotech FBIO	125 M	$ 2.71	0.04 %	$ 75.6 M	USA
Generation Bio Co. GBIO	162 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Anika Therapeutics ANIK	51.6 M	$ 21.0	2.08 %	$ 301 M	USA
Cyclacel Pharmaceuticals CYCCP	9.17 M	-	-4.36 %	$ 27 M	USA
Gracell Biotechnologies GRCL	214 M	-	-	$ 3.37 B	China
Axsome Therapeutics AXSM	99.1 M	$ 208.35	0.16 %	$ 10.4 B	USA
GlycoMimetics GLYC	163 M	-	9357.83 %	$ 1.01 B	USA
AnaptysBio ANAB	187 M	$ 57.46	2.9 %	$ 1.65 B	USA
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
AVROBIO AVRO	84 M	-	1083.1 %	$ 745 M	USA
BioMarin Pharmaceutical BMRN	1.47 B	$ 66.43	0.04 %	$ 12.7 B	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands